Circulaton: Cardiovascular Quality and Outcomes (November 2012), a journal of the American Heart Association: 5-year randomized controlled study on patients with established coronary heart disease published in the American Heart Association journal, reported a 48% reduction in death, heart attack, and stroke in subjects in the TM group compared to controls. Full abstract